Europe Uterine Cancer Market Size & Outlook, 2025-2033


Europe Uterine Cancer Market Insights

  • According to Reed Intelligence analysis, the Europe Uterine Cancer Market size stood at USD 2154.69 Million in 2024 and is forecasted to reach USD 3410.57 Million by 2033.
  • The market is projected to grow at a CAGR of 5.18% between 2026 and 2033.
  • By segment, Endometrial Adenocarcinoma was the leading By Type in terms of market size in 2024.
  • Endometrial Adenocarcinoma is expected to be the most lucrative By Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • Europe represented 34.42% of the global Uterine Cancer Market size in 2024.
  • By 2033, United States is estimated to hold the largest position in the global market in terms of size.
  • Germany is estimated to remain the fastest-growing market in Europe, advancing to USD 861.8 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 2154.69 Million
Market Size In 2033 USD 3410.57 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.18% (2025-2033)
Segmnetation Covered
Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Nordic
  8. Benelux
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends